Discontinue use if early symptoms & signs of hypersensitivity including hives, generalized urticaria, chest tightness, dyspnea, wheezing, faintness, hypotension & anaphylaxis occur. Not for treatment of factor VII deficiency. Made from pooled human plasma; may carry a risk of transmitting infectious agents, eg, viruses & the Creutzfeldt-Jakob disease agent. Do not administer at infusion rate >10 mL/min. Serious & potentially fatal thrombosis or disseminated intravascular coagulation (DIC) in patients undergoing surgery & in patients w/ known liver disease. Pregnancy. Childn ≤16 yr.
B02BD01 - coagulation factor IX, II, VII and X in combination ; Belongs to the class of blood coagulation factors. Used in the treatment of hemorrhage.
Manage Account
Change Password
Sign Out
